Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor
Open Access
- 10 June 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 8 (10) , 1030-1040
Abstract
Mesenchymal stromal cells (MSCs) are multipotent stem cells that participate in tissue repair and possess considerable immunomodulatory potential. MSCs have been shown to promote allograft survival, yet the mechanisms behind this phenomenon have not been fully defined. Here, we investigate the capacity of MSCs to suppress the allogeneic immune response by secreting the pleiotropic molecule hepatocyte growth factor (HGF). Using an in vivo mouse model of corneal transplantation, we report that MSCs promote graft survival in an HGF-dependent manner. Moreover, our data indicate that topically administered recombinant HGF (a) suppresses antigen-presenting cell maturation in draining lymphoid tissue, (b) limits T-helper type-1 cell generation, (c) decreases inflammatory cell infiltration into grafted tissue, and (d) is itself sufficient to promote transplant survival. These findings have potential translational implications for the development of HGF-based therapeutics. Stem Cells Translational Medicine 2019;8:1030–1040Keywords
Funding Information
- Eye Bank Association of America
- National Institutes of Health (P30EY003790, EY024602)
- Eye Bank Association of America
- National Institutes of Health (P30EY003790, EY024602)
This publication has 47 references indexed in Scilit:
- Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cellsImmunology & Cell Biology, 2013
- How mesenchymal stem cells interact with tissue immune responsesTrends in Immunology, 2012
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric OxideCell Stem Cell, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Hepatocyte Growth Factor Ameliorates the Progression of Experimental Autoimmune MyocarditisCirculation Research, 2005
- Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine modelAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Suppression of Acute and Chronic Rejection by Hepatocyte Growth Factor in a Murine Model of Cardiac TransplantationCirculation, 2004
- Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?Trends in Immunology, 2002
- Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic functionJournal of Clinical Investigation, 2001
- Twenty-five–Year Panorama of Corneal ImmunologyCornea, 2000